Pacira Pharmaceuticals sell JPMorgan Chase & Co.
Start price
12.08.24
/
50%
€11.10
Target price
12.08.25
€9.16
Performance (%)
87.39%
End price
13.08.25
€20.80
Summary
This prediction ended on 13.08.25 with a price of €20.80. The price for Pacira Pharmaceuticals massively increased, which is bad news for the SELL prediction by JPMorgan_Chase___Co_. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Pacira Pharmaceuticals | -3.553% | -3.553% | -21.488% |
| iShares Core DAX® | -0.383% | 1.093% | 11.642% |
| iShares Nasdaq 100 | -0.411% | -1.973% | 7.273% |
| iShares Nikkei 225® | 1.838% | 10.261% | 31.381% |
| iShares S&P 500 | -0.712% | 0.445% | 4.295% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Pacira Pharmaceuticals diskutieren
Pacira BioSciences, Inc. (NASDAQ: PCRX) had its "underweight" rating re-affirmed by analysts at JPMorgan Chase & Co.. They now have a $10.00 price target on the stock, down previously from $45.00.
Ratings data for PCRX provided by MarketBeat
In the thread Trading Pacira Pharmaceuticals
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten
Stopped prediction by JPMorgan_Chase___Co_ for Pacira Pharmaceuticals
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€28.20
07.03.24
07.03.24
€41.38
07.03.25
07.03.25
-24.11%
08.03.25
08.03.25
